On the latest episode of The Cancer SIGNAL podcast, host Susanna Quinn is joined by Nima Nabavizadeh, MD, from Oregon Health & Science University, to discuss the groundbreaking PATHFINDER 2 study findings. Listen here: https://bit.ly/48DGcwp

#EarlyCancerDetection #MCED

#LiverCancer is the fourth most common cause of cancer death worldwide, and hepatocellular carcinoma (HCC), which accounts for nearly 75% of all cases, is often diagnosed in advanced stages. We’re observing #LiverCancerAwarenessMonth by promoting #EarlyDetection.

#OctoberIs4Livers

After 20 years of serving her local police department, Darla took a multi-cancer early detection (MCED) test through her insurance company. Despite having no symptoms, her test detected a cancer signal, giving her the chance to take swift action and become cancer free today. https://bit.ly/47aCE3o

For #BreastCancerAwarenessMonth, we’re calling out the importance of #EarlyDetection—especially if you’re at risk for the BRCA gene mutation. Learn more by listening to The Cancer SIGNAL: https://bit.ly/4pTkTxc

Celebrate #InternationalPodcastDay by giving The Cancer SIGNAL a listen. On this podcast, we dive into the stories behind multi-cancer early detection (MCED)—from patients to doctors, advocates to researchers, and more. Tune in today: https://bit.ly/47oQpMD

#PodcastCommunity #EarlyCancerDetection

Tad Carper, a @dallas--cowboys.bsky.social exec, took a multi-cancer early detection (MCED) test—which led to an unexpected journey. Hear how early detection shaped his story on the latest episode of The Cancer SIGNAL podcast:

Apple Podcasts: https://apple.co/4mI2WPm

Today we announced positive top-line performance and safety results from our registrational PATHFINDER 2 study.

Learn more: grail.com/press-releas...